NovaBridge Biosciences

NBP | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.56

-$0.05 (-3.11%)

Sep 22, 2026, 10:23 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $185.58M

Enterprise Value $-810.66K

Beta 1.50

Average Volume 711.38K

Shares Outstanding (Diluted) 115.72M

Shares Change YoY 41.64%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US44975P1030

Price Performance

Price Change 1M -19.1%

Price Change 3M 0.0%

Price Change 6M -39.0%

Price Change YTD -62.3%

Price Change 1Y -58.5%

Price Change 3Y 34.2%

Price Change 5Y -97.6%

1M CAGR (ann.) -8.0%

1Y CAGR (ann.) -55.9%

5Y CAGR (ann.) -52.8%

All-Time CAGR -26.4%

Valuation

PE Ratio -2.78

Forward PE N/A

PEG Ratio -0.22

Forward PEG -0.38

PS Ratio N/A

Forward PS N/A

PB Ratio 0.92

P/FCF Ratio -5.26

P/Adj. FCF Ratio -3.29

P/OCF Ratio -5.37

EV/Sales N/A

EV/EBIT 0.01

EV/EBITDA 0.01

EV/FCF 0.02

Earnings Yield -36.0%

FCF Yield -19.0%

Adj. FCF Yield -30.4%

Financial Health

Net Cash $190.85M

Total Debt $4.46M

Cash & Short-Term Investments $190.85M

Total Assets $231.54M

Current Ratio 7.64

Quick Ratio 7.64

Debt / Equity Ratio 0.02

Debt / EBITDA -0.07

Debt / FCF -0.13

OCF / Debt -7.70

Interest Coverage 0.00

Altman Z-Score -4.59

Piotroski F-Score 1

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -59.8%

Returns

Return on Assets -21.2%

Return on Equity -1.4%

Return on Invested Capital -29.0%

Return on Capital Employed -29.2%

Return on Tangible Assets -21.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -150.0%

Revenue CAGR 5Y -37.0%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 128.2%

EPS CAGR 5Y 60.8%

EPS CAGR 10Y N/A

FCF CAGR 3Y -150.0%

FCF CAGR 5Y 76.1%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 11

EPS Growth Next 3Y -176.4%

Revenue Growth Next 3Y N/A

Earnings Date Nov 11, 2026

EPS Estimate (next Q) -$0.08

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8.25

Price Target Upside 412.4%

Cash Flow

Operating Cash Flow $-34.3M

Free Cash Flow $-35.29M

Adj. Free Cash Flow $-56.39M

FCF Per Share -$0.30

OCF Per Share -$0.30

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $0

Operating Income $-60.07M

EBITDA $-59.75M

Net Income $-49.02M

EPS (Diluted) -$0.58

Revenue / Employee N/A

Profit / Employee $-1.63M

Employees 30